MICARDIS®

MICARDIS®¹

• Primary hypertension

MICARDIS® is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

• Cardiovascular Risk Reduction

MICARDIS® is indicated for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors.

High risk for cardiovascular events can be evidenced by a history of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or high-risk diabetes (insulin-dependent or non-insulin dependent) with evidence of end-organ damage.

MICARDIS® can be used in addition to other needed treatment (such as antihypertensive, antiplatelet or lipid-lowering therapy) Studies of telmisartan in this setting do not exclude that it may not preserve a meaningful fraction of the effect of the ACE inhibitor to which it was compared. Consider using the ACE inhibitor first, and, if it is stopped for cough only, consider re-trying the ACE inhibitor after the cough resolves.

Use of telmisartan with an ACE inhibitor is not recommended.

MICARDIS PLUS®²

• Treatment of primary hypertension.

As fixed dose combination MICARDIS PLUS® is indicated in patients whose blood pressure is not adequately controlled on telmisartan or hydrochlorothiazide alone.

MICARDIS®- 1 tablet contains: [1,1’-biphenyl]-2-carboxylic acid, 4’-[(1,4’dimethyl-2’-propyl[2,6-bi- 1H-benzimidazole]-1’-yl)methyl] (= telmisartan) 40 or 80mg¹

MICARDIS PLUS®- 1 tablet contains: [1,1’-biphenyl]-2-carboxylic acid, 4’-[(1,4’dimethyl-2’-propyl[2,6-bi- 1H-benzimidazole]-1’-yl)methyl] (= telmisartan) 40 or 80mg Hydrochlorothiazide 12.5mg²